Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+969K
-
Total reported value, excl. options
-
$62.3M
-
Value change
-
+$1.74M
-
Number of buys
-
24
-
Number of sells
-
-20
-
Price
-
$1.84
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2022
57 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 72.1M outstanding shares and own 47.03% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.85M shares), EcoR1 Capital, LLC (6.12M shares), Rubric Capital Management LP (4.52M shares), VANGUARD GROUP INC (2.58M shares), Artal Group S.A. (2.5M shares), ACADIAN ASSET MANAGEMENT LLC (1.83M shares), Stonepine Capital Management, LLC (1.54M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.43M shares), Madison Avenue Partners, LP (1.39M shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (909K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.